Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Current concepts on the use of glucocorticosteroids and beta-2-adrenoreceptor agonists to treat childhood asthma.

Current opinion in pediatrics - 1 Jun 2010

Nino Gustavo, Grunstein Michael M

Abstract excerpt

PURPOSE OF REVIEW: This article reviews current concepts regarding the clinical and scientific rationale for the combined use of glucocorticosteroids and beta-2-adrenoreceptor (beta2AR) agonists in the treatment of childhood asthma. RECENT FINDINGS: Several studies have demonstrated that inhaled corticosteroids (ICS) and beta2AR agonists are the most effective medications for the management of asthma in children....

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Administration, Inhalation
Share to Adrenal Cortex Hormones

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Adrenergic beta-Agonists

Share to Anti-Asthmatic Agents

Share to Asthma

Share to Child, Preschool

Share to Drug Therapy, Combination

Share to Infant

Source

Open in PubMed Open full text

Identifiers

PMID: 20164771
DOI: 10.1097/MOP.0b013e328337cb0c
PMCID: PMC2997654

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Current concepts on the use of glucocorticosteroids and beta-2-adrenoreceptor agonists to treat childhood asthma.PMID 20164771Read ↗

Molecular Mechanisms of Combination Therapy With Inhaled Corticosteroids and Long-Acting β-AgonistsSemantic proximity Read ↗

Asthma and Corticosteroid Responses in Childhood and Adult AsthmaSemantic proximity Read ↗

Understanding how long‐acting β2‐adrenoceptor agonists enhance the clinical efficacy of inhaled corticosteroids in asthma – an updateSemantic proximity Read ↗

Evaluating combination therapies for asthma: pros, cons, and comparative benefits.Semantic proximity Read ↗

Effect of beta2-adrenergic receptor polymorphism in asthma control of patients receiving combination treatment.Semantic proximity Read ↗

Controversies regarding long-acting β2-agonists.Semantic proximity Read ↗

Benefit-risk assessment of long-acting beta2-agonists in asthma.Semantic proximity Read ↗

A medical nutrition therapy primer for childhood asthma: current and emerging perspectives.Semantic proximity Read ↗

The beta-2 adrenergic receptor and its agonists.Semantic proximity Read ↗

Effects of adding a leukotriene antagonist or a long-acting beta(2)-agonist in asthmatic patients with the glycine-16 beta(2)-adrenoceptor genotype.Semantic proximity Read ↗

Long-acting beta2-adrenoceptor agonists: a smart choice for asthma?Semantic proximity Read ↗

Safety of long-acting beta-agonists in asthma: a review.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.